Featured Products
We are an integrated specialty pharmaceutical company focused on delivering value to our customers by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals.
ANI Pharmaceuticals Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
09/10/2020
ANI Pharmaceuticals Reports Second Quarter 2020 Results
08/06/2020
$27.72
+0.47 ( 1.725% )
Pricing delayed by 20 minutes
Last updated
09/28/2020 04:00 PM
